Skip to main content
Clinical Trials/JPRN-UMIN000025409
JPRN-UMIN000025409Recruiting未知

Efficacy of Clostridium butyricum M588 probiotics for the patients of constipation in schizophrenia: 4 weeks, a randomized, double blinded trial - A randomaized trial of Clostridium butyricum M588 probiotics for the patients of constipation in schizophrenia

Fujita Health University0 sites40 target enrollmentStarted: May 19, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.Comatose patient 2.Patients under the strong influence of central nervous system depressants such as barbiturates, anesthetics 3.Patients under the influence of epinephrine 4.Patients under the influence of neurostimulatory substances such as stimulants and alcohol 5.Patients with a history of hypersensitivity to the ingredients of this drug 6.Patients who may be pregnant and pregnant 7.Patients with mental retardation 8.Patients with dementia combined 9.Patients with personality disorder complications 10.Patients diagnosed with irritable bowel syndrome by ROME III 11.Patients complicated of digestive organ diseases other than constipation 12.Patients already using live bacteria such as lactic acid bacteria and butyric acid bacteria

Investigators

Similar Trials